Skip to main content
Livermore
Livermore
ZHEN

D.A. Davidson & Co.

SEC CIK
0001080107
Latest filing
Jul 24, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by D.A. Davidson & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
4,547
Value
$2.26M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of VRTX by D.A. Davidson & Co., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20264,547$2.26M<0.1%−592−11.5%ReducedHolders
Q1 20265,139$2.29M<0.1%−112−2.1%ReducedHolders
Q4 20255,251$2.38M<0.1%+154+3.0%AddedHolders
Q3 20255,097$2.00M<0.1%+241+5.0%AddedHolders
Q2 20254,856$2.16M<0.1%+51+1.1%AddedHolders
Q1 20254,805$2.33M<0.1%−349−6.8%ReducedHolders
Q4 20245,154$2.08M<0.1%−321−5.9%ReducedHolders
Q3 20245,475$2.55M<0.1%+611+12.6%AddedHolders
Q2 20244,864$2.28M<0.1%−22−0.5%ReducedHolders
Q1 20244,886$2.04M<0.1%+2,427+98.7%AddedHolders
Q4 20232,459$1.00M<0.1%−904−26.9%ReducedHolders
Q3 20233,363$1.17M<0.1%+110+3.4%AddedHolders
Q2 20233,253$1.14M<0.1%−521−13.8%ReducedHolders
Q1 20233,774$1.19M<0.1%−567−13.1%ReducedHolders
Q4 20224,341$1.25M<0.1%+2,240+106.6%AddedHolders
Q3 20222,101$608.0K<0.1%−141−6.3%ReducedHolders
Q2 20222,242$632.0K<0.1%+61+2.8%AddedHolders
Q1 20222,181$569.0K<0.1%+948+76.9%AddedHolders
Q4 20211,233$271.0K<0.1%−3−0.2%ReducedHolders
Q3 20211,236$224.0K<0.1%+1,236NewHolders
Q2 20210$00.0%−932−100.0%Sold outHolders
Q1 2021932$200.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.